Resources

Beta Bionics starts clinical trial of iLet bionic pancreas

Beta Bionics has partnered with Zealand Pharma to study at-home use of its iLet Bionic Pancreas System with dasiglucagon for autonomous bihormonal treatment of people living with type 1 diabetes. “Fully automated diabetes care could significantly improve life...

read more

FDA grants breakthrough designation for NightWare app

Digital therapeutics startup NightWare has secured breakthrough designation from the US Food and Drug Administration (FDA) for its smart watch app meant to help patients with nightmare disorder. The NightWare app is designed to measure and treat nightmares in people...

read more

Ava reports positive results from fertility tracker study

Women’s healthcare company Ava Science has reported positive data from a clinical trial of its Fertility Tracker, a wearable device designed to identify five most fertile days of a woman’s cycle in real-time. Study data showed that the device was able to...

read more

FDA approves Stryker’s Neuroform Atlas for brain aneurysms

The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Stryker’s Neuroform Atlas Stent System for the treatment of brain aneurysms. “PMA approval of Neuroform Atlas Stent System is a significant milestone in providing world-class...

read more

K2HV secures $400M to offer life science debt financing 

K2 HealthVentures has secured $400 million to support public and private companies in life sciences and healthcare. The East Coast investor will primarily provide debt financing to enable companies to reach milestones with minimal equity dilution.

read more

Biotech Startups And The Hard Truth Of Innovation

Gary Pisano’s recent Harvard Business Review piece, The Hard Truth About Innovative Cultures, beautifully frames up how innovative corporate environments are frequently misunderstood. Innovative startups aren’t just about being cool and nimble, having...

read more

Targeted Protein Degradation Comes of Age

Translation of well validated biology into therapeutics remains one of the biggest challenges of modern drug development, in many cases due to lack of appropriate technologies to drug well credentialed biological targets. Examples in this category include driver...

read more

Getting Clinical On New Drug Launches

The IQVIA Institute released a data-rich report in April 2019 on the state of clinical R&D in the US pharmaceutical industry titled “The Changing Landscape of Research and Development: Innovation, Drivers of Change, and Evolution of Clinical Trial...

read more

A Decade of Discovery

It is with great excitement that we at Nimbus are ringing in our 10th birthday this month. It’s been a momentous decade of ups and downs, many of them chronicled in dozens of posts here on LifeSciVC. At 10 years and still going, we’re proud to...

read more

An Encyclopedia Of Advice For Startup Boards

Startups management teams often have a love-hate relationship with their Board of Directors: while Boards can be hugely helpful and constructive in the best of times, they can be dysfunctional and damaging in the worst. And most CEOs enjoy complaining about their...

read more

Maybe It’s Innate

Recently I read the article What’s Wrong With Me? that I saw re-posted on Twitter.  It’s a 2013 New Yorker article chronicling one woman’s journey through years of multi-symptom autoimmune/autoinflammatory disease with undiagnosed and...

read more